OPEN END TURBO PUT WARRANT - ASTRAZENECA ADR | Market Closed - Boerse Frankfurt Warrants 11:10:14 25/06/2024 pm IST | ||
| 3.47 EUR | -0.86% |
|
| Current month | -3.34% | ||
| 1 month | -1.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 25/24/25 | 3.47 | -0.86% |
| 24/24/24 | 3.5 | -1.69% |
| 21/24/21 | 3.56 | -0.56% |
| 20/24/20 | 3.58 | +0.28% |
| 19/24/19 | 3.57 | -0.28% |
Real-time Boerse Frankfurt Warrants
Last update June 25, 2024 at 11:10 pm IST
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | ASTRAZENECA PLC |
| Issuer | UBS |
| WKN | UM5R5E |
| ISIN | DE000UM5R5E4 |
| Date issued | 14/05/2024 |
| Strike | 116.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.63 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.78 € |
|---|---|
| Lowest since issue | 3.3 € |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
159
USD
Average target price
174.4
USD
Spread / Average Target
+9.68%
- Stock Market
- Certificates
- Certificat
